Letter: Can Addition of an Immunomodulator Really Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab?

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.13921
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Letter: Can Addition of an Immunomodulator Really Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: Double-Dose Intensification - A Quick Way to Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Letter: Double-Dose Intensification-A Quick Way to Reverse Antibody Formation and Loss of Response in Patients Treated With Adalimumab. Authors Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Suppression of Anti-Drug Antibodies to Infliximab or Adalimumab With the Addition of an Immunomodulator in Patients With Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: The Addition of an Immunosuppressant in Patients With Unsatisfactory Response to Vedolizumab

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: The Addition of an Immunosuppressant in Patients With Unsatisfactory Response to Vedolizumab-Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Addition of Methotrexate Neither Restores Clinical Response Nor Improves the Pharmacokinetic Profile of Vedolizumab-Treated Patients

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Label-Free Quantification of Anti-TNF-Α in Patients Treated With Adalimumab Using an Optical Biosensor

Sensors
InstrumentationInformation SystemsElectronic EngineeringBiochemistryAnalytical ChemistryMolecular Physics,ElectricalAtomicMedicineOptics
2018English

Dose Escalation Among Ulcerative Colitis Patients Treated With Adalimumab in Sweden

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy